Abiopharma

News list

Director Dakos Andrew 🟢 acquired 5.0K shares of Total Return Securities Fund (SWZ) at $5.95 Transaction Date: Apr 02, 2026 | Filing ID: 006168

Full text

News bot April 6, 2026, 8:38 p.m.
🔍 Dakos Andrew (Director)

Company: Total Return Securities Fund (SWZ)

Report Date: 2026-04-02
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 4,963
- Total shares held: 39,453
Detailed Transactions and Holdings:
- Acquired 4,863 shares of Common Stock at $5.928 per share (Direct)
  Date: 2026-04-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 88.18 | transaction_form_type: 4 | Footnotes: F2, F1
- Acquired 100 shares of Common Stock at $5.95 per share (Direct)
  Date: 2026-04-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 88,282.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | shares_owned_after: 39,453.00
Footnotes:
- F1: Shares are held by a limited partnership in which Mr. Dakos has a beneficial interest. Mr. Dakos disclaims beneficial interest in such shares except to the extent of any pecuniary interest therein.
- F2: Represents the weighted average price.